Saturday 17 October 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
291.67
5.52
−1.86%
Follow UFPT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
25.03 | 31.80 | 28.16 | 20.94 | 33.30 | 26.03 | 18.65 | 15.48 | 21.87 | 23.20 |
Piotroski F-Score |
5 | 5 | 6 | 6 | 2 | 5 | 7 | 6 | 7 | 5 |
P/S ratio |
2.84 | 3.72 | 3.16 | 2.47 | 2.56 | 1.94 | 1.86 | 1.16 | 1.35 | 1.27 |
Altman Z-Score |
6.86 | 6.07 | 9.24 | 6.16 | 3.95 | 10.44 | 10.95 | 5.09 | 11.24 | 10.37 |
P/FCF ratio |
21.65 | 34.89 | 40.99 | 81.85 | 58.66 | 16.79 | 14.47 | 13.82 | 28.15 | 87.58 |
Altman Z″-Score (non-manufacturers) |
6.00 | 4.95 | 6.90 | 5.55 | 4.41 | 11.77 | 10.77 | 6.83 | 14.92 | 13.96 |
Beneish M-Score |
(2.57) | (2.50) | (2.26) | (1.70) | (3.04) | (2.74) | (2.66) | (1.11) | (2.76) | (2.24) |
P/Operating CF |
101.59 | 76.76 | 99.55 | 48.87 | 858.18 | 42.02 | 41.65 | 28.40 | 44.78 | 60.94 |
P/B ratio |
4.04 | 5.47 | 4.42 | 3.68 | 2.72 | 1.97 | 2.27 | 1.57 | 1.61 | 1.64 |
Price to Tangible BV |
19.98 | 211.83 | 11.63 | 15.57 | 27.89 | 3.31 | 4.13 | 3.32 | 1.72 | 1.76 |
EV/Sales |
3.05 | 4.09 | 3.23 | 2.61 | 2.91 | 1.82 | 1.85 | 1.27 | 1.09 | 1.06 |
EV/EBITDA |
16.50 | 21.58 | 18.69 | 13.74 | 20.24 | 13.03 | 11.18 | 8.84 | 9.34 | 8.66 |
EV/Operating CF |
20.02 | 30.98 | 31.24 | 52.12 | 41.95 | 13.01 | 11.77 | 11.38 | 9.27 | 16.63 |
EV/FCF |
23.28 | 38.39 | 41.86 | 86.58 | 66.54 | 15.68 | 14.44 | 15.19 | 22.82 | 73.19 |
Quick Ratio |
1.45 | 1.35 | 1.22 | 1.06 | 1.30 | 3.35 | 1.95 | 1.64 | 6.07 | 5.59 |
Current Ratio |
2.69 | 2.56 | 2.48 | 2.08 | 2.25 | 4.75 | 3.17 | 2.69 | 7.55 | 7.31 |
Net Debt/EBITDA |
1.16 | 1.97 | 0.39 | 0.75 | 2.40 | (0.92) | (0.02) | 0.80 | (2.19) | (1.71) |
Debt/Assets |
22.81% | 32.08% | 7.92% | 14.54% | 24.58% | 0.62% | 1.64% | 13.26% | 0.00% | 0.67% |
Debt/Equity |
0.35 | 0.59 | 0.11 | 0.23 | 0.42 | 0.01 | 0.02 | 0.18 | 0.00 | 0.01 |
Asset Turnover |
0.94 | 0.98 | 1.02 | 0.99 | 0.77 | 0.92 | 1.05 | 1.16 | 1.11 | 1.18 |
Operating CF/Net income |
1.35 | 1.13 | 0.92 | 0.42 | 0.90 | 1.87 | 1.58 | 1.49 | 1.90 | 1.17 |
Capex/Depreciation |
(0.67) | (0.87) | (0.92) | (0.59) | (0.63) | (0.52) | (0.71) | (0.68) | (1.84) | (1.28) |
Interest Coverage |
9.42 | 10.04 | 15.82 | 20.05 | 544.05 | 201.59 | 36.66 | 14.86 | 233.86 | 177.35 |
| 17.82% | 18.76% | 17.16% | 19.35% | 8.56% | 7.89% | 13.06% | 10.83% | 7.78% | 7.36% | |
| 10.64% | 11.42% | 11.48% | 11.73% | 5.91% | 6.82% | 10.44% | 8.73% | 6.92% | 6.44% | |
ROIC |
10.44% | 9.52% | 11.52% | 12.02% | 5.00% | 6.79% | 9.57% | 7.55% | 8.52% | 9.26% |
Return on Tangible Assets |
33.28% | 31.17% | 30.24% | 35.28% | 15.11% | 12.10% | 21.19% | 15.45% | 7.75% | 7.32% |
Average Days of Receivables |
53.42 | 64.88 | 59.98 | 56.86 | 69.67 | 53.78 | 53.22 | 58.66 | 55.30 | 55.09 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
12.85% | 12.33% | 12.72% | 12.94% | 14.29% | 15.33% | 14.74% | 14.52% | 16.05% | 16.50% |
Intangible Assets out of Total Assets |
0.52 | 0.53 | 0.44 | 0.48 | 0.53 | 0.35 | 0.39 | 0.39 | 0.05 | 0.06 |
Share Based Compensation of Revenue |
1.47% | 1.36% | 1.16% | 0.91% | 1.18% | 1.01% | 0.80% | 0.64% | 0.72% | 0.72% |
Graham Net Nets |
(0.02) | (0.05) | 0.02 | (0.03) | (0.10) | 0.13 | 0.07 | 0.03 | 0.30 | 0.30 |
Graham Number |
104.78 | 87.94 | 70.52 | 62.45 | 35.03 | 30.85 | 36.14 | 28.89 | 22.00 | 19.82 |
Earnings Yield |
3.99% | 3.15% | 3.55% | 4.78% | 3.00% | 3.84% | 5.36% | 6.46% | 4.57% | 4.31% |
Free Cash Flow Yield |
4.62% | 2.87% | 2.44% | 1.22% | 1.70% | 5.96% | 6.91% | 7.24% | 3.55% | 1.14% |
Revenue per Share |
78.23 | 65.78 | 52.48 | 46.77 | 27.42 | 23.97 | 26.72 | 25.92 | 20.40 | 20.32 |
Operating CF per Share |
11.93 | 8.68 | 5.42 | 2.35 | 1.90 | 3.35 | 4.21 | 2.90 | 2.41 | 1.29 |
Capex per Share |
(1.67) | (1.68) | (1.38) | (0.93) | (0.70) | (0.57) | (0.78) | (0.73) | (1.43) | (1.00) |
Free Cash Flow per Share |
10.26 | 7.01 | 4.05 | 1.41 | 1.20 | 2.78 | 3.43 | 2.17 | 0.98 | 0.29 |
Cash per Share |
2.63 | 1.75 | 0.69 | 0.59 | 1.48 | 3.24 | 0.50 | 0.44 | 5.24 | 4.36 |
Shareholders Equity per Share |
55.01 | 44.70 | 37.53 | 31.40 | 25.84 | 23.64 | 21.82 | 19.12 | 17.07 | 15.72 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
55.01 | 44.70 | 37.53 | 31.40 | 25.84 | 23.64 | 21.82 | 19.12 | 17.07 | 15.72 |
Free Cash Flow |
79.03 | 53.75 | 30.85 | 10.68 | 9.01 | 20.78 | 25.46 | 15.97 | 7.09 | 2.11 |
Working Capital |
126.14 | 118.65 | 86.42 | 60.39 | 48.54 | 56.73 | 36.47 | 34.97 | 65.13 | 60.29 |
Capital Expenditures |
(12.87) | (12.85) | (10.49) | (7.06) | (5.28) | (4.26) | (5.77) | (5.35) | (10.37) | (7.19) |
Net Current Asset Value |
(30.20) | (91.29) | 26.59 | (24.30) | (52.37) | 45.55 | 26.48 | 6.49 | 60.58 | 54.97 |
EV/EBIT |
19.93 | 25.50 | 22.39 | 16.69 | 28.26 | 19.47 | 14.88 | 12.37 | 13.84 | 12.64 |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.07 | 0.05 |
Price to Operating Income |
18.53 | 23.18 | 21.93 | 15.78 | 24.91 | 20.84 | 14.91 | 11.25 | 17.08 | 15.13 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.24 | 0.21 | 0.18 | 0.20 | 0.15 | 0.15 | 0.14 | 0.14 | 0.11 | 0.12 |
Cash ROIC |
13.31% | 9.63% | 9.54% | 3.60% | 3.13% | 10.27% | 15.08% | 9.46% | 4.39% | 1.46% |
Accounts Receivable Turnover |
6.78 | 6.49 | 6.62 | 7.49 | 6.27 | 6.48 | 6.66 | 7.19 | 6.65 | 7.23 |
Accounts Payable Turnover |
17.81 | 15.37 | 13.63 | 17.24 | 21.07 | 30.97 | 25.31 | 25.81 | 27.46 | 25.93 |
Inventory Turnover |
4.96 | 4.54 | 4.65 | 6.06 | 5.96 | 7.30 | 7.63 | 8.76 | 8.32 | 7.86 |
Average Days of Payables |
20.50 | 24.76 | 28.26 | 27.65 | 24.95 | 11.17 | 11.57 | 17.55 | 13.58 | 13.10 |
Days of Inventory on Hand |
73.32 | 89.32 | 89.00 | 74.15 | 78.63 | 50.52 | 46.19 | 50.27 | 41.79 | 46.33 |
Average Receivables |
88.94 | 77.70 | 60.43 | 47.25 | 32.91 | 27.68 | 29.77 | 26.50 | 22.23 | 20.20 |
Average Payables |
24.28 | 23.28 | 21.12 | 15.29 | 7.37 | 4.35 | 5.71 | 5.51 | 4.09 | 4.30 |
Average Inventory |
87.20 | 78.86 | 61.86 | 43.49 | 26.04 | 18.46 | 18.93 | 16.22 | 13.51 | 14.18 |
Average Assets |
642.04 | 516.57 | 391.16 | 356.16 | 268.67 | 195.98 | 189.18 | 163.90 | 133.07 | 123.78 |
Average Common Equity |
383.32 | 314.43 | 261.82 | 216.00 | 185.67 | 169.44 | 151.22 | 132.08 | 118.38 | 108.31 |
Columns are period end dates